Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is mycophenolate mofetil a safe and effective treatment for patients with systemic lupus erythematosus?

Nature Clinical Practice Rheumatology volume 2, pages 16–17 (2006)Cite this article

boxed-textPisoni CN et al. (2005) Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients. J Rheum 32: 1047–1052

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Birkinshaw JH et al. (1952) Studies in the biochemistry of micro-organisms. 86. The molecular constitution of mycophenolic acid, a metabolic product of Penicillium brevi-compactum Diercks. Part III. Further observations on the structural formula for mycophenolic acid. Biochem J 50: 630–634

    Article  CAS  Google Scholar 

  2. Ginzler EM et al. (2005) A multicenter study of mycophenolate mofetil vs intravenous cyclophosphamide as induction therapy for severe lupus nephritis. N Engl J Med 353: 2219–2228

    Article  CAS  Google Scholar 

  3. Chan TM et al. (2003) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343: 1156–1162

    Article  Google Scholar 

  4. Contreras G et al. (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350: 971–980

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Clinical Professor of Medicine at the Cedars Sinai Medical Center, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

    Daniel J Wallace

Authors
  1. Daniel J Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel J Wallace.

Ethics declarations

Competing interests

The author has done consulting work for Prometheus, Aspreva and Roche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallace, D. Is mycophenolate mofetil a safe and effective treatment for patients with systemic lupus erythematosus?. Nat Rev Rheumatol 2, 16–17 (2006). https://doi.org/10.1038/ncprheum0089

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0089

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing